Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. American heart journal Cohen, A. T., Harrington, R., Goldhaber, S. Z., Hull, R., Gibson, C. M., Hernandez, A. F., Gold, A. 2015; 169 (1): 186-187

View details for DOI 10.1016/j.ahj.2014.09.004

View details for PubMedID 25497265